Traders Buy Large Volume of Call Options on Novo Nordisk A

2 days ago · Novo Nordisk A/S (NYSE:NVO - Get Free Report) was the target of unusually large options trading activity on Wednesday. Stock investors acquired 56,398 call options on the …

CouponFollow Extension

$85.83
OFF

Traders Buy High Volume Of Call Options On Novo Nordisk A/S …

2 weeks from now

1 day ago · Read Traders Buy High Volume of Call Options on Novo Nordisk A/S (NYSE:NVO) at ETF Daily News. ... Novo Nordisk A/S Trading Up 3.9 %. NVO opened at $85.83 on Thursday. …

etfdailynews.com

$6
OFF

Novo Nordisk's Options: A Look At What The Big Money Is Thinking

2 weeks from now

Oct 4, 2024 · Novo Nordisk Option Volume And Open Interest Over Last 30 Days. ... CALL: SWEEP: BULLISH: 12/20/24: $6.0: $5.85: ... Having examined the options trading patterns of …

benzinga.com

93%
OFF

Novo Nordisk Call Volume Above Normal And Directionally Bullish

2 weeks from now

Dec 2, 2024 · Bullish option flow detected in Novo Nordisk (NVO) with 11,730 calls trading, 1.4x expected, and implied vol increasing over 3 points to 50.93%. Jan-25 115 calls and Jan-25 …

nasdaq.com

4%
OFF

Novo Nordisk Stock Rises As Q4 Wegovy Sales More Than Double

2 weeks from now

2 days ago · Novo Nordisk's U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker's better-than-estimated quarterly results offset slower 2025 sales …

investopedia.com

$83.26
OFF

Stock Traders Buy High Volume Of Novo Nordisk A/S Put Options …

2 weeks from now

Jan 17, 2025 · NYSE NVO opened at $83.26 on Friday. Novo Nordisk A/S has a one year low of $80.05 and a one year high of $148.15. The company has a market cap of $373.61 billion, a …

defenseworld.net

35%
OFF

Novo Nordisk: Among The Best Opportunities Of The Moment …

2 weeks from now

2 days ago · With a P/E Ratio FWD of 30x, assuming analysts' estimates of 2025 EPS are correct ($3.84), Novo Nordisk should be trading at least $115 per share by year-end, a 35% …

seekingalpha.com

FAQs about Traders Buy Large Volume of Call Options on Novo Nordisk A Coupon?

Is Novo Nordisk A/S a good buy?

BNP Paribas raised Novo Nordisk A/S to a “strong-buy” rating in a research report on Monday, December 2nd. Cantor Fitzgerald restated an “overweight” rating and set a $160.00 price target on shares of Novo Nordisk A/S in a report on Wednesday, November 6th. ...

Did capital Performance Advisors LLP buy Novo Nordisk A/S?

Capital Performance Advisors LLP acquired a new stake in shares of Novo Nordisk A/S in the third quarter valued at approximately $42,000. Albion Financial Group UT grew its position in shares of Novo Nordisk A/S by 121.4% during the fourth quarter. ...

Where does Novo Nordisk work?

(Get Free Report) Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. ...

Will Novo Nordisk meet soaring demand in 2024?

Record investments in 2024 to enhance supply chain and production capacity highlight Novo Nordisk's commitment to meeting soaring demand. Double-digit growth in revenue and operating income expected for 2025, with promising guidance and a current undervaluation based on a P/E Ratio FWD of just 22x. ...

How do I receive news & ratings for Novo Nordisk A/S?

Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter. ...

Is Novo Nordisk a good investment in 2024?

Overall, Novo Nordisk is in the midst of a new long-term growth cycle, but the only problem is that it does not have the right infrastructure to meet the massive demand. For this reason, 2024 was a record year for investment. Suffice it to say that CapEx + Acquisitions amount to 45% of total sales in 2024. ...